Angioplasty Balloons Market Tendencies, Revenue Forecast, and Interesting Opportunities from 2020 to 2027
Angioplasty
Balloons Market Highlights
Angioplasty Balloons Market size is
anticipated to hold a value of USD 3457.35 Million by 2027 and is expected to
register a CAGR of 5.01% during the assessment period of 2020 to 2027.
The
Global Angioplasty Balloons Market is driven by several factors, such as technological advancements in
balloons, increasing preference for minimally invasive procedures, surging
prevalence of cardiac diseases, rising initiatives by public and private
organizations to create awareness regarding angioplasty treatment options,
increasing product launches and several clinical trials by the prominent
players in the market. For instance, the European Atherosclerosis Society (EAS)
creates awareness related to new developments and innovations to prevent
atherosclerosis.
A lot
of market players are dominating the global angioplasty balloons market. The prominent players are involved in strategic
agreements, product launches and joint ventures to sustain their market
positions. For instance, in August 2017, C.R. Bard, a part of Becton, Dickinson
and Company, received US Food and Drug Administration (FDA) premarket approval
for its Latonia drug-coated balloon to treat a new indication, stenosis in the
arteriovenous (AV) fistulae of patients with end-stage renal disease.
Regional
Analysis
The
market has been divided, by region, into the Americas, Europe, Asia-Pacific,
and the Middle East & Africa. The Americas held the maximum share in 2019,
owing to the high incidence rates of cardiac disorders, and strategic
activities by major players in countries such as the US. The angioplasty
balloons market in the Americas has further been branched into North America
and Latin America, with the North American market divided into the US and
Canada. The European angioplasty balloons market has been categorized as
Western Europe and Eastern Europe. The Western European market has further been
classified as Germany, France, the UK, Italy, Spain, and the rest of Western
Europe. The European market for angioplasty balloons is expected to hold a
substantial share owing to the increase in the number of cardiac disorder
cases. The angioplasty balloons market in Asia-Pacific has been segmented into
Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The
angioplasty balloons market in this region is anticipated to be the fastest
growing during the forecast period due to the increasing uptake and adoption
rate of newer treatment options by medical professionals. The increasing
patient pool and mortality rate due to cardiac diseases in these countries also
fuel the market growth. For instance, in 2017, ischemic heart disease was the
second-highest cause for death in Japan. The angioplasty balloons market in the
Middle East & Africa has been divided into the Middle East and Africa.
Segmentation
The
global angioplasty balloons market has been segmented based on type,
application, and end user.
The
market types of balloons used in
angioplasty are normal balloons, cutting
balloons, drug eluting balloons, and scoring balloons. The market, based on
normal balloons, held a major share in 2018 owing to the widespread use and
high preference rate. The drug eluting balloons segment is expected to be the fastest-growing
segment during the forecast period due to the continued innovations by players.
The
market, based on application, has been segmented into coronary artery disease
and peripheral artery disease. The coronary artery disease segment held the largest
share in 2019 owing to the increased cardiac cases across the globe, whereas
the peripheral artery segment is anticipated to be the fastest-growing segment
due to the increasing strategic initiatives by key players in this segment by
prominent players.
The
global angioplasty balloons market report has been segmented, based on end user, into
hospitals, cardiac catheterization laboratories, ambulatory surgical centers,
and others. The hospitals segment held the majority share of the market in 2019
owing to the increasing number of patient admissions due to cardiac diseases,
whereas the cardiac catheterization laboratories segment is projected to be the
fastest-growing segment during the study period owing to the increasing
preference of these labs by medical professionals.
Key
Players
The
global angioplasty balloons market players are B. Braun Melsungen AG (Germany),
Abbott (US), Biotronik SE & Co. KG (Germany), C.R. Bard (BD) (US), Boston
Scientific Corporation (US), Cook (US), Medtronic (Ireland), Koninklijke Philips
N.V. (Netherlands), Terumo Medical Corporation (Japan), Cordis (Cardinal
Health) (US), and Endocor (Germany).
About Market
Research Future:
At Market Research
Future (MRFR), we enable our customers to unravel the complexity of various industries
through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR),
& Consulting Services. MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients.
Contact us:
Market Research
Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,
5Th Floor,
New York, New York
10013
United States of
America
+1 628 258 0071
Email:
sales@marketresearchfuture.com
Comments
Post a Comment